National Cancer Institute; Notice of Closed Meetings, 576-577 [2010-33287]
Download as PDF
<![CDATA[
576
Federal Register / Vol. 76, No. 3 / Wednesday, January 5, 2011 / Notices
Dated: December 28, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2010–33239 Filed 1–4–11; 8:45 am]
National Cancer Institute; Notice of
Closed Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
jlentini on DSKJ8SOYB1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
President’s Cancer Panel.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: President’s Cancer
Panel.
Date: February 1, 2011.
Time: 8 a.m. to 4 p.m.
Agenda: The Future of Cancer Research:
Accelerating Scientific Innovation.
Place: Grand Hyatt Atlanta, 3300 Peachtree
Road, NE., Atlanta, GA 30305.
Contact Person: Abby B. Sandler, PhD,
Executive Secretary, Chief, Institute Review
Office, Office of the Director, 6116 Executive
Blvd., Suite 220, MSC 8349, National Cancer
Institute, NIH, Bethesda, MD 20892–8349,
(301) 451–9399, sandlera@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/pcp/pcp.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 28, 2010.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–33291 Filed 1–4–11; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
16:26 Jan 04, 2011
Jkt 223001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SPORE in
Mesothelioma, Lung, Breast and Ovarian
Cancers.
Date: February 2–3, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Wlodek Lopaczynski,
M.D., PhD, Scientific Review Officer,
Research Programs Review Branch, Division
of Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8131,
Bethesda, MD 20892, 301–594–1402,
lopacw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Development of Molecular Diagnostics Assay
to Detect Basal-like Breast Cancer.
Date: February 15, 2011.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 703, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Lalita D. Palekar, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7141, Bethesda,
MD 20892, 301–496–7575,
palekarl@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Systems for
Automated Storage, Analysis, and Reporting
of Objective Behavioral Exposures.
Date: February 16–17, 2011.
Time: 8:30 a.m. to 11 a.m.
Agenda: To review and evaluate contract
proposals.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Contact Person: Ellen K Schwartz, E.D.D.,
M.B.A., Scientific Review Officer, Special
Review & Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8055B, Bethesda, MD 20892–8329,
301–594–1215, schwarel@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Collaborative Research in Integrative Cancer
Biology and the Tumor Microenvironment.
Date: February 16, 2011.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 8055A,
Rockville, MD 20852, (Telephone Conference
Call)
Contact Person: Zhiqiang Zou, M.D., PhD,
Scientific Review Officer, National Cancer
Institute, National Institutes of Health, 6116
Executive Blvd., Room 8055A, MSC 8329,
Bethesda, MD 20852, zouzhiq@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Smartphone Applications for Cancer
Prevention and Control.
Date: February 17, 2011.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Ellen K Schwartz, E.D.D.,
M.B.A., Scientific Review Officer, Special
Review & Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8055B, Bethesda, MD 20892–8329,
301–594–1215, schwarel@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Nanotechnology Sensing Platforms.
Date: March 2, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Savvas C Makrides, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Rm 8050a, Bethesda,
MD 20892, 301–496–7421,
makridessc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Innovative
Technology Development.
Date: March 2–3, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Jeffrey E. DeClue, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 8059,
Bethesda, MD 20892–8329, 301–496–7904,
decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
E:\FR\FM\05JAN1.SGM
05JAN1
jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 76, No. 3 / Wednesday, January 5, 2011 / Notices
Nanotechnology Therapeutics and
Theranostics.
Date: March 3, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Savvas C Makrides, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Rm 8050a, Bethesda,
MD 20892, 301–496–7421,
makridessc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Development of Blood-based Methods for the
Detection of Cancer Recurrence in PostTherapy Breast Cancer Patients.
Date: March 3, 2011.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 703, Rockville,
MD 20852, (Telephone Conference Call)
Contact Person: Lalita D. Palekar, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7141, Bethesda,
MD 20892, 301–496–7575,
palekarl@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; High Level
Programming Language to Expedite
Development of User Interfaces.
Date: March 8, 2011.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 607, Rockville,
MD 20852, (Telephone Conference Call)
Contact Person: Marvin L. Salin, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 7073,
Bethesda, MD 20892–8329, 301–496–0694,
msalin@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NonCoding RNAs and Cancer.
Date: March 10, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Thomas M Vollberg, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7142, Bethesda,
MD 20892, 301–594–9582,
vollbert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Health
Information Technology to Facilitate PatientCentered Communication in Cancer Related
Care.
Date: March 10, 2011.
Time: 12 p.m. to 3 p.m.
VerDate Mar<15>2010
16:26 Jan 04, 2011
Jkt 223001
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 607, Rockville,
MD 20852, (Telephone Conference Call)
Contact Person: Marvin L. Salin, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 7073,
Bethesda, MD 20892–8329, 301–496–0694,
msalin@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; MultiCenter Clinical Trials.
Date: March 14, 2011.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 8103, Rockville,
MD 20852, (Telephone Conference Call)
Contact Person: Timothy C. Meeker, M.D.,
PhD, Scientific Review Officer, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
8103, Bethesda, MD 20892, (301) 594–1279,
meekert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 28, 2010.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–33287 Filed 1–4–11; 8:45 am]
BILLING CODE 4140–01–P
577
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Therapeutic Strategies for Cancer.
Date: February 2–4, 2011.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Majed M. Hamawy,
M.B.A., PhD, Scientific Review Officer,
Research Programs Review Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8135, Bethesda, MD 20852, 301–594–
5659, mh101v@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; K99 and
T32 Review.
Date: February 22, 2011.
Time: 5 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Sergei Radaev, PhD,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8117, Bethesda, MD 20892, 301–435–
5655, sradaev@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 28, 2010.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–33285 Filed 1–4–11; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5415–C–20]
Notice of Funding Availability (NOFA)
for HUD’s Fiscal Year 2010; Resident
Opportunity and Self-Sufficiency
(ROSS)—Service Coordinators
Program; Extension of Application Due
Date
Office of the Assistant
Secretary for Public and Indian
Housing, HUD.
ACTION: Notice of Funding Availability
for HUD’s Fiscal Year (FY) 2010
Resident Opportunity and SelfSufficiency (ROSS) Service
Coordinators Program; Extension of
Application Due Date.
AGENCY:
E:\FR\FM\05JAN1.SGM
05JAN1
]]>Agencies
[Federal Register Volume 76, Number 3 (Wednesday, January 5, 2011)]
[Notices]
[Pages 576-577]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-33287]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SPORE in Mesothelioma, Lung, Breast and Ovarian Cancers.
Date: February 2-3, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Wlodek Lopaczynski, M.D., PhD, Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Blvd., Room
8131, Bethesda, MD 20892, 301-594-1402, lopacw@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Development of Molecular Diagnostics Assay to Detect Basal-
like Breast Cancer.
Date: February 15, 2011.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 703, Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Lalita D. Palekar, PhD, Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Boulevard,
Room 7141, Bethesda, MD 20892, 301-496-7575, palekarl@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Systems for Automated Storage, Analysis, and Reporting of
Objective Behavioral Exposures.
Date: February 16-17, 2011.
Time: 8:30 a.m. to 11 a.m.
Agenda: To review and evaluate contract proposals.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Ellen K Schwartz, E.D.D., M.B.A., Scientific
Review Officer, Special Review & Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Boulevard, Room 8055B, Bethesda, MD 20892-8329, 301-594-
1215, schwarel@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Collaborative Research in Integrative Cancer Biology and the
Tumor Microenvironment.
Date: February 16, 2011.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 8055A, Rockville, MD 20852, (Telephone Conference Call)
Contact Person: Zhiqiang Zou, M.D., PhD, Scientific Review
Officer, National Cancer Institute, National Institutes of Health,
6116 Executive Blvd., Room 8055A, MSC 8329, Bethesda, MD 20852,
zouzhiq@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Smartphone Applications for Cancer Prevention and Control.
Date: February 17, 2011.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate contract proposals.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Ellen K Schwartz, E.D.D., M.B.A., Scientific
Review Officer, Special Review & Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Boulevard, Room 8055B, Bethesda, MD 20892-8329, 301-594-
1215, schwarel@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Nanotechnology Sensing Platforms.
Date: March 2, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Savvas C Makrides, PhD, Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm
8050a, Bethesda, MD 20892, 301-496-7421, makridessc@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Innovative Technology Development.
Date: March 2-3, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Jeffrey E. DeClue, PhD, Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 8059, Bethesda, MD 20892-8329, 301-496-7904,
decluej@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel;
[[Page 577]]
Nanotechnology Therapeutics and Theranostics.
Date: March 3, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Savvas C Makrides, PhD, Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm
8050a, Bethesda, MD 20892, 301-496-7421, makridessc@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Development of Blood-based Methods for the Detection of
Cancer Recurrence in Post-Therapy Breast Cancer Patients.
Date: March 3, 2011.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 703, Rockville, MD 20852, (Telephone Conference Call)
Contact Person: Lalita D. Palekar, PhD, Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Boulevard,
Room 7141, Bethesda, MD 20892, 301-496-7575, palekarl@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; High Level Programming Language to Expedite Development of
User Interfaces.
Date: March 8, 2011.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 607, Rockville, MD 20852, (Telephone Conference Call)
Contact Person: Marvin L. Salin, PhD, Scientific Review Officer,
Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694,
msalin@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Non-Coding RNAs and Cancer.
Date: March 10, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Thomas M Vollberg, PhD, Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Boulevard,
Room 7142, Bethesda, MD 20892, 301-594-9582, vollbert@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Health Information Technology to Facilitate Patient-Centered
Communication in Cancer Related Care.
Date: March 10, 2011.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 607, Rockville, MD 20852, (Telephone Conference Call)
Contact Person: Marvin L. Salin, PhD, Scientific Review Officer,
Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694,
msalin@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Multi-Center Clinical Trials.
Date: March 14, 2011.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 8103, Rockville, MD 20852, (Telephone Conference Call)
Contact Person: Timothy C. Meeker, M.D., PhD, Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 8103, Bethesda, MD 20892, (301) 594-1279,
meekert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 28, 2010.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-33287 Filed 1-4-11; 8:45 am]
BILLING CODE 4140-01-P
